Although the putative preventive and therapeutic effects of statins in the treatment of various cancers, including mesothelioma, require further investigation, their effects on the mevalonate pathway have been confirmed to control YAP1/TAZ activity [110], such that statin treatment inhibits both YAP1/TAZ nuclear localization and transcriptional responses [110]. Here, YAP1 is linked to cancer.